On Oct 31, major Wall Street analysts update their ratings for $Fortive (FTV.US)$, with price targets ranging from $77 to $95.
Morgan Stanley analyst Christopher Snyder maintains with a buy rating, and maintains the target price at $89.
Citi analyst Andrew Kaplowitz maintains with a buy rating, and adjusts the target price from $98 to $92.
Barclays analyst Julian Mitchell maintains with a buy rating, and adjusts the target price from $98 to $95.
Wells Fargo analyst Joe O'Dea maintains with a hold rating, and maintains the target price at $77.
RBC Capital analyst Deane Dray maintains with a hold rating, and adjusts the target price from $85 to $77.
Furthermore, according to the comprehensive report, the opinions of $Fortive (FTV.US)$'s main analysts recently are as follows:
The anticipated decline in performance for Fluke / IOS has now taken place, which may clear the way for improved stock performance leading into 2025.
Fortive's third-quarter earnings were below expectations, influenced by IOS softness along with a combination of deferred government spending and a generally weaker market in China. These elements have led to a reduced forecast for 2024 organic sales. Following a year dedicated to preparing for a spin-off and a halt on mergers and acquisitions, Fortive might currently be navigating a state of indecision, weighing the potential risks and benefits.
The performance of AHS was noted to be positive this quarter, yet disappointments in IOS and PT organic following the reiteration in early September had an adverse effect on the stock. Despite the shares being considered undervalued, the Q3 underperformance is not expected to alleviate the uncertainties surrounding the impending spin-off.
Here are the latest investment ratings and price targets for $Fortive (FTV.US)$ from 6 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美東時間10月31日，多家華爾街大行更新了$Fortive (FTV.US)$的評級，目標價介於77美元至95美元。
摩根士丹利分析師Christopher Snyder維持買入評級，維持目標價89美元。
花旗分析師Andrew Kaplowitz維持買入評級，並將目標價從98美元下調至92美元。
巴克萊銀行分析師Julian Mitchell維持買入評級，並將目標價從98美元下調至95美元。
富國集團分析師Joe O'Dea維持持有評級，維持目標價77美元。
加皇資本市場分析師Deane Dray維持持有評級，並將目標價從85美元下調至77美元。
此外，綜合報道，$Fortive (FTV.US)$近期主要分析師觀點如下：
Fluke / IOS的表現預期下降已經發生，這可能爲2025年的股票表現改善鋪平道路。
fortive第三季度收入低於預期，受IOS軟件力以及中國市場總體疲軟與政府支出推遲的影響。這些因素導致了2024年有機銷售的預測下調。在一個專注於準備剝離和暫停併購的一年後，fortive目前可能正處於搖擺狀態，權衡潛在風險與利益。
AHS在本季度的表現被認爲積極，然而IOS和Pt有機在9月初重申後的失望對股價產生了不利影響。儘管股票被認爲被低估，第三季度的表現不會減輕圍繞即將進行的剝離的不確定性。
以下爲今日6位分析師對$Fortive (FTV.US)$的最新投資評級及目標價：
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
